Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control. Prevention and control of influenza.
These recommendations update information on the vaccine and antiviral agent available for controlling influenza during the 1988-89 influenza season (superseding MMWR 1987;36:373-380,385-387). Changes include statements about 1) updating of the influenza strains in the trivalent vaccine for 1988-89, 2) increased emphasis on the need for vaccination of health-care workers, 3) prevention of influenza in persons with human immunodeficiency virus (HIV) infection, and 4) dosage considerations for amantadine.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000008:administration & dosage; D002648:Child; D003428:Cross Infection / Q000517:prevention & control; D005260:Female; D006801:Humans; D009980:Influenza A virus; D009981:Influenza B virus; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000209:etiology / Q000517:prevention & control*; D011247:Pregnancy; D012307:Risk Factors; D014481:United States; D015164:Vaccines, Inactivated
D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D000547:Amantadine